Arrowhead Pharmaceuticals Inc
ARWRHealthcare|Biotechnology|USA
$59.50
-1.62 (-2.65%)
Tangible Book
$4.09
Graham Number
$11.87
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202609",
"202709",
"202809"
],
"revenue_estimate": [
451.18,
321.4,
541.79
],
"ebit_estimate": [
-444.73,
-584.54,
-416.23
],
"ebitda_estimate": [
-314.77,
-437.65,
-490.62
],
"net_income_estimate": [
-502.7,
-602.98,
-444.26
],
"per_share_eps_estimate": [
-3.45,
-4.19,
-2.97
],
"eps_nri_estimate": [
-3.46,
-4.2,
-2.97
],
"dividend_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
3.84,
5.14,
2.67
],
"pretax_income_estimate": [
-490.89,
-602.48,
-444.26
],
"operating_cash_flow_per_share_estimate": [
-2.36,
-1.13,
null
],
"roa_estimate": [
null,
null,
null
],
"roe_estimate": [
-25.98,
-68.41,
-63.87
],
"gross_margin_estimate": [
99.55,
96.93,
96.37
],
"operating_cash_flow_estimate": [
-332.07,
-159,
null
],
"pettm_estimate": [
0,
0,
0
],
"long_term_growth_rate_mean": -462.71,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": -462.46,
"future_eps_nri_estimate_growth": -462.71,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": -447.59,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": -372,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709"
],
"revenue_estimate": [
75.69,
37.44,
38.21,
42.6,
31.17,
33.87,
158.03
],
"ebit_estimate": [
-177.37,
-192.36,
-151.27,
-204.79,
-211.39,
-216.33,
-161.59
],
"ebitda_estimate": [
-173.66,
-183.34,
-147.9,
null,
null,
null,
null
],
"net_income_estimate": [
-171.59,
-200.89,
-173.92,
-216.49,
-223.14,
-229.13,
-173.44
],
"per_share_eps_estimate": [
-1.18,
-1.39,
-1.13,
-1.36,
-1.46,
-1.49,
-1.21
],
"eps_nri_estimate": [
-1.19,
-1.4,
-1.23,
-1.36,
-1.46,
-1.49,
-1.21
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-166.2,
-198.23,
-174.49,
-216.24,
-222.64,
-228.38,
-172.44
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
98.8,
96.33,
96.27,
97.9,
96.9,
95.9,
95.4
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
null,
null,
null
],
"long_term_growth_rate_mean": -462.71,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": -462.46,
"future_eps_nri_estimate_growth": -462.71,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": -447.59,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": -372,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}